QKI and adenocarcinoma: To identify splicing factors that control lung cancer-associated splicing changes, we analyzed mRNA expression levels of 59 known splicing factors in microarray data collected from 80 normal and 104 adenocarcinoma patient samples [22]–[24] and found that QKI is one of the splicing factors frequently down-regulated (Figure S1).